glp 1 anesthesia guidelines 2025 asa for GLP-1 agonists and risk: Assessment of gastric content using ultrasound asa glp 1 guidelines – Perioperative management of patients taking

GLP-1 medications are typically considered for adults who: Have a Body Mass Index (BMI) of 30 or higher Have a BMI of 27 or higher with weight-related conditions such as diabetes or hypertension Have not achieved sustained weight loss through lifestyle modification alone These medications are intended for long-term weight management, not short-term or cosmetic weight loss

While these drugs are designed for long-term use in disease management, many individuals use GLP-1s for a limited periodeither to jump-start weight loss before transitioning to a lifestyle-based maintenance or due to financial constraints

Enhanced Insulin Sensitivity Hyperinsulinemia contributes to ovarian androgen production via stimulation of theca cells and suppression of hepatic sex hormonebinding globulin (SHBG)

Today marks a turning point: more choice, lower costs, and a genuine commitment to care built around the whole patient